China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.
China Bans Illumina Sequencer Imports as Trade Tensions Rise
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US ...
MedTech Dive9d
Illumina’s DNA sequencers hit with China import ban
Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...
C&EN11d
Sequencing DNA by converting it into an accordion molecule
Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...
San Diego Union-Tribune12d
Illumina cuts workforce at San Diego headquarters
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
Illumina sees 2025 EPS of $4.50 after China ban, consensus $4.51
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...
Investing27d
Illumina's SWOT analysis: stock outlook amid sequencing market shifts
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.